July 23, 2025
In this Pharmacy Times byline, Chief Pharmacy Officer at Pleio Mark Gregory, RPh and Director of Specialty Pharmacy at Gentry Health Services, Katie Warmuth, PharmD, CSP explore how a human-first support model led to improved adherence and outcomes in specialty pharmacy. As automation rises, their insights show why empathy remains essential for patient success.
June 13, 2025
Jennifer Butler, Chief Commercial Officer, Pleio, and Rimesh Patel, RPh, MBA, Chief Operating Officer, Gentry Health, discuss a new collaboration between Pleio and Gentry Health Services. This collaboration leverages peer-to-patient support to address emotional barriers in the specialty medication journey, boosting adherence, improving patient experience, and delivering measurable results.
June 11, 2025
“OLLIE gives pharmaceutical companies a more honest view of the emotional and behavioral realities that shape adherence, grounded not in assumptions but in patients’ own words.” – Michael Oleksiw, Chief Executive Officer at Pleio
May 22, 2025
Drug Store News features Pleio’s report revealing loneliness as a major barrier in chronic care. With 74% of patients reporting that loneliness negatively affects their physical health, the study highlights the need for peer support to improve outcomes and patient engagement.
May 22, 2025
Medication non-adherence costs the U.S. $500B annually. Pleio’s new AI, OLLIE, identifies emotional barriers through patient conversation analysis, empowering human supporters to intervene with empathy and improve outcomes.
May 7, 2025
Jen Butler, chief commercial officer at Pleio, and Mark Gregory, chief pharmacy officer at Pleio, sat down for an interview with Pharmacy Times at Asembia’s AXS25 Summit. They discussed the critical role of emotional support in specialty pharmacy. Drawing on insights from a recent report, Butler and Gregory highlighted the importance of addressing patient barriers in improving medication adherence.
FOR MEDIA INQUIRIES PLEASE EMAIL media@pleio.com.